Skip to main content
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,813.00
+5.60 (0.31%)
Mar 10, 2026, 10:50 AM IST

NSE:SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 155.21B INR in the quarter ending December 31, 2025, with 13.49% growth. This brings the company's revenue in the last twelve months to 568.09B, up 10.09% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.

Revenue (ttm)
568.09B
Revenue Growth
+10.09%
P/S Ratio
7.63
Revenue / Employee
13.21M
Employees
43,000
Market Cap
4,336.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Divi's Laboratories 103.14B
Cipla 279.67B
Zydus Lifesciences 260.89B
Mankind Pharma 139.14B
Aurobindo Pharma 331.82B
Alkem Laboratories 142.53B
Glenmark Pharmaceuticals 165.10B
Laurus Labs 67.22B
Revenue Rankings

Sun Pharmaceutical Industries News

More News